- CA$27.80m
- CA$31.70m
- $14.52m
- 57
- 48
- 29
- 41
Annual income statement for Aurora Spine, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 11.2 | 8.65 | 10.5 | 14.9 | 14.5 |
| Cost of Revenue | |||||
| Gross Profit | 3.55 | 3.47 | 4.83 | 7.81 | 8.21 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 12.4 | 9.9 | 13.3 | 16.4 | 16.2 |
| Operating Profit | -1.25 | -1.25 | -2.71 | -1.57 | -1.68 |
| Gain / Loss on Sale of Assets | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -1.25 | -0.232 | -2.36 | -1.5 | -1.68 |
| Net Income After Taxes | -1.25 | -0.232 | -2.36 | -1.5 | -1.68 |
| Net Income Before Extraordinary Items | |||||
| Net Income | -1.25 | -0.232 | -2.36 | -1.5 | -1.68 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -1.25 | -0.232 | -2.36 | -1.5 | -1.68 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -0.027 | -0.004 | -0.04 | -0.022 | -0.024 |